WORLD HEALTH ORGANIZATION EXECUTIVE BOARD 115th Session Provisional agenda item 9.1 EB115/27 Add.1 7 January 2005
Expert committees and study groups Membership of expert advisory panels and meetings of expert committees Report by the Secretariat1
ESTABLISHMENT OR DISESTABLISHMENT OF EXPERT ADVISORY PANELS 1. The WHO Expert Advisory Panel on Human Cell, Tissue and Organ Transplantation was established. The WHO expert advisory panels on health situation and trend assessment, on organization of medical care, and on public health administration were disestablished.
MEMBERSHIP OF THE EXPERT ADVISORY PANELS 2. Membership of the 52 expert advisory panels totalled 880 in December 2004, compared with 1064 in December 2003. Of the regional distribution of all members of all panels, 8% come from the African Region, 24% from the Region of the Americas, 10% from the South-East Asia Region, 37% from the European Region, 9% from the Eastern Mediterranean Region and 12% from the Western Pacific Region. Of the total of all members of all panels, 21% are women. 3. Attached is a list of all panels, which includes a breakdown of members by panel, region and sex, as of December 2004. Further details (alphabetical list of experts giving nationality) can be made available should members of the Board so request.
MEETINGS OF EXPERT COMMITTEES 4. The following committees met in 2004: Advisory Committee on Health Research (42nd Session), Geneva, 3-5 May (11 members: eight men, three women); (43rd Session), Geneva, 16-20 November (14 members: 11 men, three women) This report is submitted to the Executive Board in compliance with Regulation 4.23 of the Regulations for Expert Advisory Panels and Committees. 1
EB115/27 Add.1
Joint FAO/WHO Expert Committee on Food Additives (62nd Session), Rome, 4-12 February 2004 (five WHO members: five men); (63rd Session) Geneva, 8-17 June (eight WHO members: five men, three women) Expert Committee on Biological Standardization, Geneva, 15-18 November (nine members: eight men, one woman) Expert Committee on Specifications for Pharmaceutical Preparations, Geneva 25-29 October (10 members: six men, four women) 5. Invitations to take part in these meetings were extended to 57 panel members from 26 different countries, drawn from 10 expert advisory panels (three members were unable to attend).
2
MEMBERSHIP OF WHO EXPERT ADVISORY PANELS BY PANEL AND REGION Numbers of panel members, as of December 2004 WHO expert advisory panels Acute bacterial diseases Acute diarrhoeal diseases and other enteric infections Ageing and health Biological standardization Blood transfusion medicine Brucellosis Cancer Cardiovascular diseases Chronic degenerative diseases (diabetes) Chronic degenerative diseases (rheumatic diseases) Clinical surgical procedures Development of human resources for health Drug dependence (dependence liability evaluation) Drug dependence and alcohol problems Drug evaluation Drug policies and management Food safety Health laboratory services Health promotion and education Health science and technology policy Human genetics Human reproduction Immunology Injury and violence prevention and control International pharmacopoeia and pharmaceutical preparations Leprosy Malaria Maternal and child health Africa N 0 0 2 0 3 0 0 2 2 0 1 1 0 0 4 6 4 3 0 4 2 0 0 0 8 0 1 0 W 0 0 2 0 0 0 0 0 0 0 0 1 0 0 1 2 0 0 0 2 0 0 0 0 1 0 0 0 The Americas N W 4 0 4 8 3 1 9 3 3 1 2 3 6 3 6 5 16 6 0 5 7 1 5 4 11 4 2 3 0 0 3 2 2 0 2 0 0 0 0 1 1 2 2 0 4 1 0 1 1 1 0 1 8 0 0 0 South-East Asia N W 1 2 1 1 2 0 2 2 1 1 1 2 0 1 4 4 2 1 0 2 2 2 3 1 2 4 3 2 0 2 0 0 1 0 1 0 1 0 0 0 0 0 2 1 1 1 0 1 0 0 0 0 2 0 0 0 Europe N 5 1 11 14 5 0 7 7 7 0 1 7 2 9 9 8 15 12 0 5 11 1 7 2 29 4 13 0 W 0 0 2 2 1 0 0 0 1 0 0 0 0 3 3 5 1 3 0 0 1 0 0 1 10 1 0 0 Eastern Mediterranean N W 2 0 2 1 3 0 0 3 1 0 2 3 2 1 5 1 0 5 1 1 2 0 1 0 5 2 2 5 0 0 1 0 2 0 0 0 0 0 0 0 0 0 1 0 0 2 1 0 1 0 0 0 0 0 0 2 Western Pacific N W 0 1 1 1 2 0 0 4 2 0 0 2 4 4 2 8 5 2 0 4 2 1 3 0 9 1 2 1 0 0 0 0 1 0 0 0 0 0 0 0 1 1 2 3 0 1 0 2 0 1 0 0 0 0 0 1 Total N 12 4 21 25 18 1 18 21 16 2 7 18 14 18 30 32 42 29 1 21 26 5 19 7 64 15 23 11 W 0 2 8 4 7 0 3 0 2 0 0 2 2 6 11 11 6 8 1 6 3 2 0 2 21 1 0 3 % 0 50 38 16 39 0 17 0 13 0 0 11 14 33 37 34 14 28 100 29 12 40 0 29
EB115/27 Add.1
33 7 0 27
3
4 WHO expert advisory panels Mental health Neurosciences Nursing Nutrition Oral health Parasitic diseases (filarial infections) Parasitic diseases (general parasitology) Parasitic diseases (leishmaniasis) Parasitic diseases (schistosomiasis) Parasitic diseases (trypanosomiases) Prevention of blindness Prevention of deafness and hearing impairment Rabies Radiation Rehabilitation Respiratory infections Sexually transmitted infections including those due to human immunodeficiency virus Traditional medicine Tuberculosis Vector biology and control Virus diseases Virus diseases (antivirals and interferon) Zoonoses Total Africa N 1 1 2 0 2 3 3 0 2 1 2 0 1 0 0 0 1 2 4 2 1 0 0 71 W 0 0 2 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 0 15 21%
EB115/27 Add.1
The Americas N W 7 1 4 5 1 1 7 1 7 10 6 3 3 2 1 0 6 4 6 8 4 0 2 214 1 0 4 0 0 0 2 0 0 5 2 0 0 0 0 0 1 1 1 0 0 0 0 49 23%
South-East Asia N W 4 1 4 1 3 2 2 1 0 0 2 1 1 0 0 0 1 2 2 5 3 0 2 86 2 1 4 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 2 1 0 0 26 30%
Europe N 16 7 3 5 9 4 15 7 9 7 4 4 1 3 0 1 4 0 7 14 5 1 3 321 W 2 1 3 2 1 0 2 0 0 0 0 1 0 0 0 0 1 0 3 2 0 0 0 52 16%
Eastern Mediterranean N W 2 0 3 5 2 0 2 0 3 0 2 1 2 1 0 0 0 0 3 3 0 0 0 79 0 0 3 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 17 16%
Western Pacific N W 6 0 3 4 2 0 3 0 7 0 5 2 0 0 1 1 0 1 5 6 1 0 1 109 3 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 22 20%
Total N 36 10 19 20 19 10 32 9 28 18 21 11 8 6 2 2 12 9 27 38 14 1 8 880 W 8 2 19 4 2 1 5 0 1 5 3 2 0 0 0 0 2 2 8 5 1 0 0 181 % 22 20 100 20 11 10 16 0 4 28 14 18 0 0 0 0 17 22 30 13 7 0 0 21
= = =
N: total number of panel members; W: number of women members; %: total number of panel members who are women.